NF2 and meningioma: They identified 4 molecular subgroups of meningioma, MG1-4, and designated each subgroup based on pathway analysis of enriched genes: immunogenic (MG1), benign NF2 wild-type (MG2), hypermetabolic (MG3), and proliferative (MG4).